Abstract
The effect of acute exposure to cigarette smoke (CS) on the respiratory system has been less extensively studied than the long term effects of smoking. The aim of the present study was to evaluate the acute response to CS in smokers suffering from chronic obstructive pulmonary disease (COPD) and in healthy smokers. Nineteen stable COPD patients and 19 young healthy smokers were enrolled. Tumor necrosis factor alpha (TNF-α), IL-1β, and malondialdehyde (MDA) were measured in exhaled breath condensate (EBC) before and 60 min after smoking a cigarette. When pre- and post-CS levels of the evaluated biomarkers were compared, no differences were found in either group. However, the post-CS MDA was significantly greater in healthy smokers than that in COPD patients; 20.41 vs. 16.81 nmol/L, p = 0.01, respectively. Post-CS TNF-α correlated inversely with FEV1/FVC in healthy smokers. We conclude that CS does not acutely increase the EBC concentration of the inflammatory markers either in COPD patients or healthy smokers. The short term CS-induced oxidative stress is higher in young smokers than in COPD patients, which what may indicate a higher susceptibility to CS content of the former.
The original version of this chapter has been revised. An erratum to this chapter can be found at DOI 10.1007/978-3-319-44488-8_11
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bartoli ML, Novelli F, Costa F, Malagrino L, Melosini L, Bacci E, Cianchetti S, Dente FL, Di Franco A, Vagaggini B, Paggiaro PL (2011) Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases. Mediators Inflamm. doi:10.1155/2011/891752
Comandini A, Rogliani P, Nunziata A, Cazzola M, Curradi G, Saltini C (2009) Biomarkers of lung damage associated with tobacco smoke in induced sputum. Respir Med 103:1592–1613
Corradi M, Massimo I, Andreoli R, Manini P, Caglieri A, Poli D, Alinovi R, Mutti A (2003) Aldehydes in exhaled breath condensate in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:1380–1386
Durak I, Bingӧl NK, Avci A, Cimen MY, Karaca L, Ozturk HS (2000) Acute effects of smoking of cigarettes with different tar content on plasma oxidant/antioxidant status. Inhal Toxicol 12:641–647
Fletcher C, Peto R (1977) The natural history of chronic airflow limitation. Br Med J 1:1645–1648
Garey KW, Neuhauser MM, Robbins RA, Danziger LH, Rubinstein I (2004) Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 125:22–26
GOLD (2015) Global initiative for obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2015 update. http://www.goldcopd.org. Accessed 18 Jan 2016
Górska K, Maskey-Warzęchowska M, Krenke R (2010) Airway inflammation in chronic obstructive pulmonary disease. Curr Opin Pulm Med 16:89–96
Hoonhorst SJM, Timens W, Koenderman L, Lo Tam Loi AT, Lammers JW, Boezen HM, van Oosterhout AJ, Postma DS, Ten Hacken NH (2014) Increased activation of blood neutrophils after cigarette smoking in young individuals susceptible to COPD. Respir Res 15:121–130
Horvath I, Hunt J, Barnes PJ et al (2005) Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26:523–548
Koczulla AR, Noeske S, Herr C, Jӧrres RA, Rӧmmelt H, Vogelmeier C, Bals R (2010) Acute and chronic effects of smoking on inflammation markers in exhaled breath condensate in current smokers. Respiration 79:61–67
Konstantinidi EM, Lappas AS, Tzortzi AS, Behrakis PK (2015) Exhaled breath condensate: technical and diagnostic aspects. ScientificWorldJournal 2015:435160. doi:10.1155/2015/435160
Kostikas K, Minas M, Nikolaou E et al (2013) Secondhand smoke exposure induces acutely airway acidification and oxidative stress. Respir Med 107:172–179
Kotz D, van de Kant K, Jöbsis Q, van Schayck CP (2007) Effects of tobacco exposure on lung health and pulmonary biomarkers in young, healthy smokers aged 12–25 years: a systematic review. Expert Rev Respir Med 1:403–418
Lommatzsch M, Bratke K, Knappe T, Bier A, Dreschler K, Kuepper M, Stoll P, Julius P, Virchow JC (2010) Acute effects of tobacco smoke on human airway dendritic cells in vivo. Eur Respir J 35:1130–1136
Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319–338
Papaioannou AI, Koutsokera A, Tanou K, Kiropoulos TS, Tsilioni I, Oikonomidi S, Liadaki K, Pournaras S, Gourgoulianis KI, Kostikas K (2010) The acute effect of smoking in healthy and asthmatic smokers. Eur J Clin Investig 40:103–109
Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26:948–968
Rovina N, Koutsoukou A, Koulouris NG (2013) Inflammation and immune response in COPD: where do we stand? Mediators Inflamm 2013:413735. doi:10.1155/2013/413735
Ryder MI, Saghizadeh M, Ding Y, Nguyen N, Soskolne A (2002) Effects of tobacco smoke on the secretion of interleukin 1β, tumor necrosis factor α and transforming growth factor β from peripheral blood mononuclear cells. Oral Microbiol Immunol 17:331–336
Tanni SE, Pelegrino NRG, Angeleli AYO, Correa C, Godoy I (2010) Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J Inflamm 7:29–35
van der Toorn M, Slebos DJ, de Bruin HG, Gras R, Rezayat D, Jorge L, Sandra K, Oosterhout AJ (2013) Critical role of aldehydes in cigarette smoke-induced acute airway inflammation. Respir Res 14:45–56
van der Vaart H, Postma DS, Timens W, ten Hacken NH (2004) Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 59:713–721
van der Vaart H, Postma DS, Timens W, Hylkema MN, Willemse BW, Boezen HM, Vonk JM, de Reus DM, Kauffman HF, ten Hacken NH (2005) Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respir Res 6:22–32
WCRF (2016) World Cancer Research Fund International. Lung cancer statistics. http://www.wcrf.org/int/cancer-facts-figures. Accessed 18 Jan 2016
WHO (2016) Prevalence of tobacco use. Global health observatory data. http://www.who.int/gho/tobacco/use. Accessed 18 Jan 2016.
Acknowledgements
The authors would like to thank Piotr Korczynski for his assistance in the preparation of the manuscript.
Conflicts of Interest
The authors declare no conflict of interest related to the contents of this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Maskey-Warzęchowska, M. et al. (2016). Acute Response to Cigarette Smoking Assessed in Exhaled Breath Condensate in Patients with Chronic Obstructive Pulmonary Disease and Healthy Smokers. In: Pokorski, M. (eds) Respiratory Treatment and Prevention. Advances in Experimental Medicine and Biology(), vol 944. Springer, Cham. https://doi.org/10.1007/5584_2016_43
Download citation
DOI: https://doi.org/10.1007/5584_2016_43
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-44487-1
Online ISBN: 978-3-319-44488-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)